Health Services · Medical/Nursing Services · NSE: LALPATHLAB · data 2026-10-09

Dr. Lal PathLabs Limited

Health check: Strong (8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,933.6

Market cap

₹31,877 cr

P/E

59.7

P/B

—

ROE

21.6%

ROCE

25.3%

Debt / equity

0.08

Dividend yield

0.84%

1-year return

26.3%

52-week high

₹2,038.6

52-week low

₹1,272.6

Operating margin

23.0%

Growth

Revenue (last 12 months)	₹2,891 cr
Net profit (last 12 months)	₹542 cr
Sales growth, 3 years (yearly)	11.1%
Profit growth, 3 years (yearly)	28.3%

Chart patterns

Double top — forming (key level ₹1,865)

Similar companies

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Metropolis Healthcare Ltd. (METROPOLIS) · Thyrocare Technologies Ltd (THYROCARE) · Nephrocare Health Services Limited (NEPHROPLUS)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open LALPATHLAB in NSE Scanner →